documents: FDA-2021-P-0895-0003

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2021-P-0895-0003 FDA FDA-2021-P-0895 Petition Response from FDA CDER to Eagle Pharmaceuticals Other Agency Response 2021-12-29T05:00:00Z 2021 12 2021-12-29T05:00:00Z   2021-12-29T13:27:34Z   0 0 0900006484f0002f

Links from other tables